The authors demonstrated that TET1 binds to the promoter region of the TP53 tumor suppressor gene and promotes its expression in bladder cancer cells (T24), whereas XIST inhibits the expression of TP53 by binding to TET1. The gene discussed is TP53; the disease is urinary bladder cancer.